These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica. Robinson-Agramonte MA; Gonçalves CA; Portela LV; Saiz-Hinarejos A; Oses JP; Motta LS; Muller AP; Marquez Gonzalez ME; Souza DO Neuroimmunomodulation; 2010; 17(3):177-9. PubMed ID: 20134196 [TBL] [Abstract][Full Text] [Related]
10. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients. Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202 [TBL] [Abstract][Full Text] [Related]
11. Increased soluble C5b-9 in CSF of neuromyelitis optica. Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854 [TBL] [Abstract][Full Text] [Related]
12. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675 [TBL] [Abstract][Full Text] [Related]
13. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009 [TBL] [Abstract][Full Text] [Related]
14. Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients. Tüzün E; Kürtüncü M; Türkoğlu R; Içöz S; Pehlivan M; Birişik O; Eraksoy M; Akman-Demir G J Neuroimmunol; 2011 Apr; 233(1-2):211-5. PubMed ID: 21215465 [TBL] [Abstract][Full Text] [Related]
15. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. Smith CH; Waubant E; Langer-Gould A J Neuroophthalmol; 2009 Jun; 29(2):104-6. PubMed ID: 19491632 [TBL] [Abstract][Full Text] [Related]
16. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621 [TBL] [Abstract][Full Text] [Related]
17. The spectrum of neuromyelitis optica. Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564 [TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding. Kim JS; Cheon S; Kim SW; Kim B; Kim H; Park KD; Kim SM Biochem Biophys Res Commun; 2016 Sep; 478(2):553-8. PubMed ID: 27462020 [TBL] [Abstract][Full Text] [Related]
19. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Kalluri SR; Illes Z; Srivastava R; Cree B; Menge T; Bennett JL; Berthele A; Hemmer B Arch Neurol; 2010 Oct; 67(10):1201-8. PubMed ID: 20937947 [TBL] [Abstract][Full Text] [Related]